Breaking
•Russia says it arrests two suspected Polish spies in Kaliningrad, Interfax reports - Reuters•Why Anthropic CEO Dario Amodei wanted OpenAI to stop taking Peter Thiel’s money•Germany sells €1.08B in 30-year bond auction - Breakingthenews.net•Noah Kahan to Headline Record-Breaking Six Nights at Fenway Park on His 2027 World Tour - Holler Country•Women’s soccer claims record-breaking ninth NESCAC title - The Williams Record•New 25-Item Scale Measures the Operating Room Learning Environment for Anaesthesiology Residents in Türkiye - Bioengineer.org•Kazakhstan Launches Climate Investment Platform at COP31 With Up to $1 Billion in Potential EBRD Financing - The Astana Times•Atmospheric Rivers into Western Europe - Climate Impact Company•Voters rejected Prop. 45. The battle over California’s housing crisis continues - Los Angeles Times•Thunberg and Guterres blast oil companies for "fossil fuel addiction" - Euronews.com•Global Leaders Told to Fight Harder as Key Climate Goal Fails - Bloomberg.com•UN chief urges world leaders to tackle fossil fuels at COP31 - AFP.com•In Medias Res: Ned Lamont must prioritize climate action in his third term - dailycampus.com•Pat Cummins filmed in tense exchange with wife Becky amid fallout from Usman Khawaja claims - The Australian•Liverpool should have had penalty for shirt-pull on Alexander Isak, panel rules - Irish Independent•Pochettino used USMNT ‘losers’ and $10m divorce for Premier League dream job - talkSPORT•Blue Jackets ‘running out of time to get it going’ after aimless loss to Florida - The New York Times•Why the Mets’ offseason hinges on landing Tarik Skubal - The New York Times•Canadiens lose, but honour Carey Price by becoming more like his best teams - The New York Times•What I’m hearing on Guardians’ payroll, pursuits and coaching changes at GM meetings - The New York Times•Russia says it arrests two suspected Polish spies in Kaliningrad, Interfax reports - Reuters•Why Anthropic CEO Dario Amodei wanted OpenAI to stop taking Peter Thiel’s money•Germany sells €1.08B in 30-year bond auction - Breakingthenews.net•Noah Kahan to Headline Record-Breaking Six Nights at Fenway Park on His 2027 World Tour - Holler Country•Women’s soccer claims record-breaking ninth NESCAC title - The Williams Record•New 25-Item Scale Measures the Operating Room Learning Environment for Anaesthesiology Residents in Türkiye - Bioengineer.org•Kazakhstan Launches Climate Investment Platform at COP31 With Up to $1 Billion in Potential EBRD Financing - The Astana Times•Atmospheric Rivers into Western Europe - Climate Impact Company•Voters rejected Prop. 45. The battle over California’s housing crisis continues - Los Angeles Times•Thunberg and Guterres blast oil companies for "fossil fuel addiction" - Euronews.com•Global Leaders Told to Fight Harder as Key Climate Goal Fails - Bloomberg.com•UN chief urges world leaders to tackle fossil fuels at COP31 - AFP.com•In Medias Res: Ned Lamont must prioritize climate action in his third term - dailycampus.com•Pat Cummins filmed in tense exchange with wife Becky amid fallout from Usman Khawaja claims - The Australian•Liverpool should have had penalty for shirt-pull on Alexander Isak, panel rules - Irish Independent•Pochettino used USMNT ‘losers’ and $10m divorce for Premier League dream job - talkSPORT•Blue Jackets ‘running out of time to get it going’ after aimless loss to Florida - The New York Times•Why the Mets’ offseason hinges on landing Tarik Skubal - The New York Times•Canadiens lose, but honour Carey Price by becoming more like his best teams - The New York Times•What I’m hearing on Guardians’ payroll, pursuits and coaching changes at GM meetings - The New York Times
TheNewsPulse.pro
Home/clinical trials/diseases/drugs
clinical_trials

Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer

Confidence95·multiple reportsImportance97NP-EVT-20261111-C2F7108

Nature Medicine, Published online: 11 November 2026; doi:10.1038/s41591-026-04716-9 This work developed and validated a computational pathology biomarker—the TROP2 normalized membrane ratio—that quantifies subcellular TROP2 localization and predicts improved progression-free and overall survival with datopotamab deruxtecan in patients with nonsquamous non-small-cell lung cancer lacking actionable genomic alterations.

Read the original at the primary source
Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer
Jacob Sands · 11/11/2026, 12:00:00 AM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse

Discussion

ChatsPulse · 0 threads

No discussion yet. Sign in and start the first thread —